Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Augmentation index and large-artery remodeling in patients with longstanding rheumatoid arthritis compared with healthy controls
Seminars in Arthritis and Rheumatism, 06/30/09
Pieringer H et al. – Study demonstrates that augmentation index (Aix), a marker of arterial stiffness, as well as intima-media thickness (IMT), a marker of large-artery remodeling, are increased in rheumatoid arthritis (RA) patients without traditional cardiovascular (CV) risk factors. Measuring AIx might assist in better assessing the increased CV risk in RA pts.
Methods- Study was undertaken to:
- Investigate whether AIx is increased in RA pts w/o traditional CV risk factors and
- Evaluate whether there is an interrelationship with large artery remodeling as ascertained by carotid ultrasound
- 36 RA pts (age: 46.4±7.7 yrs; 31 female); were eligible for analysis if they had no traditional CV risk factors
- AIx was assessed noninvasively during pulse wave analyses
- For large artery remodeling IMT was measured in both common carotid arteries with ultrasound
- Results were compared with 36 age- and sex-matched controls
- AIx was higher in RA pts vs controls
- In addition, IMT was higher in RA pts
- In RA pts there was a positive correlation between IMT and AIx
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study
Arthritis Care and Research , 11/03/09
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor [alpha] therapies: Does the risk change with the time since start of treatment?
Arthritis & Rheumatism, 11/05/09
Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A 15-year follow-up
Scandinavian Journal of Rheumatology , 09/28/09
Sponsor
Article Search
Sponsor


See Latest Articles


